Orion Oyj (OTCMKTS:ORINF) Sees Significant Growth in Short Interest

Orion Oyj (OTCMKTS:ORINF) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 623,300 shares, an increase of 24.9% from the February 13th total of 498,900 shares. Based on an average trading volume of 300 shares, the days-to-cover ratio is currently 2,077.7 days.

Orion Oyj Stock Performance

OTCMKTS:ORINF remained flat at $48.65 on Tuesday. Orion Oyj has a 1 year low of $48.65 and a 1 year high of $48.65. The firm has a fifty day moving average price of $48.65 and a two-hundred day moving average price of $47.98.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.